Disc Medicine to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at four upcoming investor conferences:
- Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 3rd at 10:55 a.m. ET.
- 2025 Wells Fargo Healthcare Conference on Thursday, September 4th at 4:30 p.m. ET.
- H.C. Wainwright 27th Annual Global Investment Conference on Tuesday, September 9th at 12:00 p.m. ET.
- Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10th at 1:05 p.m. ET.
Live webcasts of the fireside chats will be available through the investor relations section of the Company's website at and an archived replay will be available after the event.
About Disc Medicine
Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit .
Media Contact
Peg Rusconi
Deerfield Group
Investor Relations Contact
Christina Tartaglia
Precision AQ
